login

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

NaturePublished 1 December 1985
Jerry M. Adams, A. W. Harris, Carl A. Pinkert, Lynn M. Corcoran, Warren S. Alexander, Suzanne Cory
Citations1,785
SJR quartileQ1
SJR score18.29
SNIP10.16

TL;DR

Transgenic mice bearing the cellular myc oncogene coupled to the immunoglobulin μ or κ enhancer frequently develop a fatal lymphoma within a few months of birth and constitutive c-myc expression appears to be highly leukaemogenic at several stages of B-cell maturation.

Abstract

Transgenic mice bearing the cellular myc oncogene coupled to the immunoglobulin mu or kappa enhancer frequently develop a fatal lymphoma within a few months of birth. Since the tumours represent represent both immature and mature B lymphocytes, constitutive c-myc expression appears to be highly leukaemogenic at several stages of B-cell maturation. These myc mice should aid study of lymphoma development, B-cell ontogeny and immunoglobulin regulation.

Keywords

MedicineBiochemistry, Genetics and Molecular Biology